Key facts
- Notable investors include 3LC Venture GmbH, Bioventure, Hildesheim GmbH & Co. KG, Sana Biotechnology, Sartorius — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Repairon
- ·The full record, as it builds
Funding rounds
No funding rounds for Repairon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Repairon
Developer of tissue engineering technologies designed to repair failing organs. The company specializes in providing strong data for safety, feasibility, and function from pre-clinical models and works for sustainable re-muscularization of the failing heart, enabling patients suffering from advanced heart failure to meet medical needs through new regenerative treatment.
- Sector
- Healthcare
- HQ
- Göttingen, Germany
- Founded
- 2014
- Employees
- 15
- Website
- repairon.de/
- Ownership
- Privately Held (backing)
Repairon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Repairon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Repairon in its N-PORT filings yet. We sweep new filings monthly.